Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines.
| Autor: | La Monica, Silvia1, Cretella, Daniele1, Bonelli, Mara1, Fumarola, Claudia1, Cavazzoni, Andrea1, Digiacomo, Graziana1, Flammini, Lisa2, Barocelli, Elisabetta2, Minari, Roberta3, Naldi, Nadia3, Petronini, Pier Giorgio1, Tiseo, Marcello3 mtiseo@ao.pr.it, Alfieri, Roberta1 roberta.alfieri@unipr.it |
|---|---|
| Zdroj: | Journal of Experimental & Clinical Cancer Research (17569966). 12/4/2017, p1-12. 12p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|